Email list hosting service & mailing list manager

NIH "negative carryforward" allowable? Sara Richey (11 Oct 2022 17:04 EST)
Re: NIH "negative carryforward" allowable? Bobbie Ursin (12 Oct 2022 09:59 EST)
Re: [RESADM-L] NIH "negative carryforward" allowable? Lindsey Demeritt (12 Oct 2022 10:23 EST)
Listserv for job postings? Diana Key (12 Oct 2022 10:29 EST)

Re: NIH "negative carryforward" allowable? Bobbie Ursin 12 Oct 2022 09:59 EST
Sara,

Carryover from one budget period to the next is only restricted if this is stipulated in the award notice.

Bobbie Ursin
Semi-retired
________________________________________
From: xxxxxx@lists.healthresearch.org <xxxxxx@lists.healthresearch.org> on behalf of Sara Richey <xxxxxx@kp.org>
Sent: Tuesday, October 11, 2022 3:04:33 PM
To: xxxxxx@lists.healthresearch.org
Subject: [RESADM-L] NIH "negative carryforward" allowable?

Hello All,

I am writing with a question about budget periods on NIH grants. Historically I’ve always been under the impression that money from future budget years cannot be used to cover overruns in prior years during the project period of performance (i.e. year 3 funds cannot be used to cover a year 2 overrun). This was regardless of the type of project (i.e. expanded authority or not).

However, after doing some digging in the NIH Grants Policy Statement and the Code of Federal Regulations, I can’t find any policy that explicitly states that anywhere. I’m wondering how other institutions handle situations like these when they arise. Do you allow for negative carryforward between budget periods on a grant? Can anyone point to an NIH policy that disallows a negative carryforward between budget years, as long as the budget years are part of the same project period?

The only explicit thing I could find related to this question was in the NIH Grants Policy Statement, which talked about disallowing cost transfers between competitive segments to cover an overrun.

Transfers of costs from one project to another or from one competitive segment to the next solely to cover cost overruns are not allowable (emphasis mine).
https://grants.nih.gov/grants/policy/nihgps/html5/section_7/7.5_cost_transfers__overruns__and_accelerated_and_delayed_expenditures.htm<https://urldefense.com/v3/__https:/grants.nih.gov/grants/policy/nihgps/html5/section_7/7.5_cost_transfers__overruns__and_accelerated_and_delayed_expenditures.htm__;!!BZ50a36bapWJ!vCgLwCdIMZhpY0Dg5aMLuHTkcBQ6kZtKBbeXS7v_rPiivhYO5KYz-8xNklvzew3ZFaAyAkeOQQ-_jrxmEShV$>

Any insight would be much appreciated!

Sara

Sara Richey, MPA
Senior Sponsored Projects Administrator
Institute for Health Research | Kaiser Permanente Colorado
2550 S. Parker Rd., Suite 200 | Aurora, CO  80014
P: 303-636-2926 | F: 303-636-2943 |  xxxxxx@kp.org<mailto:xxxxxx@kp.org>
[cid:image001.png@01D8DD8A.4ADAACA0]
NOTICE TO RECIPIENT:  If you are not the intended recipient of this e-mail, you are prohibited from sharing, copying, or otherwise using or disclosing its contents.  If you have received this e-mail in error, please notify the sender immediately by reply e-mail and permanently delete this e-mail and any attachments without reading, forwarding or saving them. v.173.295  Thank you.

- = - = - = - = - = - = -

This email was sent to xxxxxx@NAU.EDU via the Research Administrator's mailing list.

To unsubscribe from RESADM-L, go to https://lists.healthresearch.org and go into the Account Settings area.

List archives are available at: https://lists.healthresearch.org/resadm-l

To change your settings (such as Digest Mode or to temporarily suspend list emails): https://lists.healthresearch.org